Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Drugmaker to sell cheaper generic rival to EpiPen injectors
Source: Associated Press
Drugmaker to sell cheaper generic rival to EpiPen injectors
By LINDA A. JOHNSON
December 6, 2018
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.
The penlike injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.
Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair, including one from EpiPen seller Mylan. The company started selling its own generic after it was blasted for repeated hikes that pushed up its list price from $94 to $608 for a pair of brand-name EpiPens.
What people pay varies, though, depending on insurance, discounts and the pharmacy.
-snip-
By LINDA A. JOHNSON
December 6, 2018
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.
The penlike injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.
Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair, including one from EpiPen seller Mylan. The company started selling its own generic after it was blasted for repeated hikes that pushed up its list price from $94 to $608 for a pair of brand-name EpiPens.
What people pay varies, though, depending on insurance, discounts and the pharmacy.
-snip-
Read more: https://apnews.com/5bd084d64c1740e896f6f80aeff23aa2
